Stockscreener 앱 받기
3.62
4.23%
-0.16
시간 외 거래:
3.60
-0.02
-0.55%
전일 마감가:
$3.78
열려 있는:
$3.68
하루 거래량:
131.09K
Relative Volume:
0.21
시가총액:
$96.36M
수익:
$50.14M
순이익/손실:
$-35.38M
주가수익비율:
-2.5857
EPS:
-1.4
순현금흐름:
$-39.46M
1주 성능:
-1.09%
1개월 성능:
-34.66%
6개월 성능:
-60.82%
1년 성능:
-67.59%
1일 변동 폭
$3.60
$3.91
1주일 범위
$3.60
$4.02
52주 변동 폭
$3.60
$14.16
Avita Medical Inc Stock (RCEL) Company Profile
명칭
Avita Medical Inc
전화
661-568-1317
주소
28159 AVENUE STANFORD, VALENCIA, CA
RCEL을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
RCEL
Avita Medical Inc
|
3.62 | 102.13M | 50.14M | -35.38M | -39.46M | -1.40 |
|
ABT
Abbott Laboratories
|
125.80 | 215.34B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
98.84 | 146.15B | 19.35B | 2.78B | 3.49B | 1.8696 |
|
SYK
Stryker Corp
|
362.61 | 136.97B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
90.42 | 115.69B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
84.15 | 48.77B | 5.88B | 1.34B | 577.90M | 2.3455 |
Avita Medical Inc Stock (RCEL) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-08-08 | 다운그레이드 | BTIG Research | Neutral → Sell |
| 2024-12-24 | 개시 | D. Boral Capital | Buy |
| 2024-04-11 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2023-06-27 | 개시 | Cantor Fitzgerald | Overweight |
| 2021-03-02 | 개시 | Piper Sandler | Overweight |
| 2020-08-27 | 개시 | BofA Securities | Buy |
| 2020-04-21 | 개시 | Oppenheimer | Outperform |
| 2020-03-03 | 개시 | BTIG Research | Buy |
모두보기
Avita Medical Inc 주식(RCEL)의 최신 뉴스
Historical volatility pattern of AVITA Medical Inc. visualizedWeekly Profit Analysis & Technical Pattern Recognition Alerts - newser.com
Is AVITA Medical Inc. stock a top pick in earnings seasonMarket Sentiment Report & Free Growth Oriented Trading Recommendations - newser.com
How AVITA Medical Inc. stock performs in interest rate cyclesProfit Target & Fast Exit/Entry Strategy Plans - newser.com
AVITA Medical Inc Stock Analysis and ForecastTop Performing Stocks & Backtest Your Strategy Before You Risk Money - earlytimes.in
How risky is AVITA Medical Inc. stock now2025 Market Outlook & AI Driven Stock Movement Reports - newser.com
Is it too late to sell AVITA Medical Inc.July 2025 Action & Verified Swing Trading Watchlist - newser.com
Why AVITA Medical Inc. stock remains a top recommendationQuarterly Investment Review & Safe Entry Momentum Tips - newser.com
AVITA Medical's RECELL System Highlights Clinical and Economic B - GuruFocus
Data Presented at the 2025 Southern Region Burn Conference Reinforce RECELL® System as a Standard of Care in Acute Wound Treatment - Investing News Network
AVITA Medical (NASDAQ: RCEL) data show up to 97.55% donor site reduction with RECELL - Stock Titan
How AVITA Medical Inc. stock performs during Fed tightening cyclesGlobal Markets & Detailed Earnings Play Alerts - newser.com
How to escape a deep drawdown in AVITA Medical Inc.Trade Risk Assessment & Daily Volume Surge Trade Alerts - newser.com
How AVITA Medical Inc. stock performs in weak economyJuly 2025 Closing Moves & AI Powered Buy/Sell Recommendations - newser.com
Is AVITA Medical Inc. stock attractive for ETFsJuly 2025 Short Interest & AI Optimized Trading Strategy Guides - newser.com
How analysts rate AVITA Medical Inc. stock todayQuarterly Earnings Report & AI Based Buy/Sell Signal Reports - newser.com
Using AI based signals to follow AVITA Medical Inc.2025 AllTime Highs & Free Daily Entry Point Trade Alerts - newser.com
Is AVITA Medical Inc. stock attractive for income investors2025 Performance Recap & AI Powered Buy and Sell Recommendations - newser.com
Will AVITA Medical Inc. stock benefit from commodity prices2025 Price Targets & Fast Entry High Yield Stock Tips - newser.com
Is AVITA Medical Inc. stock a buy for dividend growth2025 Market Sentiment & Breakout Confirmation Trade Signals - newser.com
Leading vs lagging indicators on AVITA Medical Inc. performanceTrade Analysis Report & AI Powered Buy/Sell Recommendations - newser.com
AVITA Medical, Inc. (RCEL) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Avita Medical gets FDA approval for ReCell skin regeneration device supplement - new.smallcaps.com.au
Published on: 2025-11-01 12:29:56 - newser.com
AVITA MEDICAL INC CDI 5:1 (AVHHL.US) is scheduled to release its earnings report after the market close on November 6. - 富途牛牛
Avita Medical (RCEL) to Release Quarterly Earnings on Thursday - MarketBeat
Can AVITA Medical Inc. stock hit analyst price targetsRisk Management & Free High Accuracy Swing Entry Alerts - newser.com
Will AVITA Medical Inc. stock outperform Nasdaq index2025 Short Interest & Growth Oriented Trading Recommendations - newser.com
Bronstein, Gewirtz & Grossman, LLC Encourages AVITA Medical, Inc. (RCEL) Investors to Inquire about Securities Investigation - ACCESS Newswire
Avita Medical Inc (RCEL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.47%
0.23%
자본화:
|
볼륨(24시간):